H.R. 7967

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7967 Introduced in House (IH)]

<DOC>

119th CONGRESS
2d Session
H. R. 7967

To require the Secretary of Health and Human Services to revise the 
Mandatory Guidelines for Federal Workplace Drug Testing Programs to 
include testing for methadone use and to require the Secretary of 
Transportation to issue regulations to include testing for methadone 
use in Department of Transportation drug tests.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

March 17, 2026

Mr. Smith of New Jersey introduced the following bill; which was 
referred to the Committee on Oversight and Government Reform, and in 
addition to the Committee on Transportation and Infrastructure, for a 
period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
committee concerned

_______________________________________________________________________

A BILL

To require the Secretary of Health and Human Services to revise the 
Mandatory Guidelines for Federal Workplace Drug Testing Programs to 
include testing for methadone use and to require the Secretary of 
Transportation to issue regulations to include testing for methadone 
use in Department of Transportation drug tests.

Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as ``Heidi's Law''.

SEC. 2. INCLUSION OF TESTING FOR METHADONE USE IN CERTAIN DRUG TESTING 
PROCEDURES.

(a) Revision of Mandatory Guidelines.--Not later than 90 days after 
the date of enactment of this Act, the Secretary of Health and Human 
Services shall revise the Mandatory Guidelines for Federal Workplace 
Drug Testing Programs, established pursuant to section 503(a) of Public 
Law 100-71 (5 U.S.C. 7301 note), to expand the opiate category on the 
list of substances authorized for testing to include methadone.
(b) Publication of Notice.--Upon completion of the revision 
required under subsection (a), the Secretary shall publish a final 
notice in the Federal Register of such revision.

SEC. 3. INCLUSION OF METHADONE IN DEPARTMENT OF TRANSPORTATION DRUG 
TESTS.

Not later than 60 days after the final notice required under 
section 2(b) is published, the Secretary of Transportation shall issue 
such regulations as are necessary to update any regulations containing 
procedures for transportation employee workplace drug and alcohol 
testing programs to include testing for methadone use in drug-testing 
panels, consistent with the Mandatory Guidelines for Federal Workplace 
Drug Testing Programs as revised by the Secretary of Health and Human 
Services under section 2.

SEC. 4. TO COMPEL THE SECRETARY TO PERIODICALLY UPDATE THE MANDATORY 
GUIDELINES FOR FEDERAL WORKPLACE DRUG TESTING.

(a) In General.--On an annual basis, the Secretary of Health and 
Human Services shall review and if necessary revise the Mandatory 
Guidelines for Federal Workplace Drug Testing Programs, established 
pursuant to section 503(a) of Public Law 100-71 (5 U.S.C. 7301 note), 
to expand the list of substances authorized for testing to include any 
such drugs which may not have been previously included, and which the 
Secretary believes should be included.
(b) Publication of Notice.--Upon completion of the revision 
required under subsection (a), the Secretary shall publish a final 
notice in the Federal Register of such revision.

SEC. 5. INCLUSION OF NEWLY ESTABLISHED DRUGS IN DEPARTMENT OF 
TRANSPORTATION DRUG TESTS.

Not later than 60 days after the final notice required under 
section 4(b) is published, the Secretary of Transportation shall issue 
such regulations as are necessary to update any regulations containing 
procedures for transportation employee workplace drug and alcohol 
testing programs to include testing for newly identified substances in 
drug-testing panels, consistent with the Mandatory Guidelines for 
Federal Workplace Drug Testing Programs as revised by the Secretary of 
Health and Human Services under section 4.
<all>